Every 8-K that INTEGRATED WELLNESS UTS (WELUF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow WELUF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WELUF filings page.
Integrated Wellness Acquisition Corp describes how public shareholders can redeem their shares in connection with both its approved business combination with Btab Ecommerce Group, Inc. and a proposed deadline extension. Shareholders may redeem in connection with the December 8, 2025 Business Combination Meeting or the March 12, 2026 Extension Meeting, or both.
As of December 31, 2025, the estimated per share redemption price was approximately $12.91, including accrued interest and less taxes. The company explains different outcomes depending on whether the Extension to September 16, 2026 is implemented and clarifies how shareholders can confirm, withdraw, or resubmit redemption requests through its transfer agent.
Integrated Wellness Acquisition Corp provides an update on its planned business combination with Btab Ecommerce Group, Inc. and the expected leadership of the post‑merger public company, Pubco. The transaction involves two mergers that will make both IWAC and Btab wholly owned subsidiaries of Pubco, with Btab’s Class A and Class V common shares converting into Pubco Class A and Class V shares at the Company Merger Effective Time.
The filing explains that IWAC shareholders had previously approved the nomination of Daniel Kennedy as a Pubco director, effective at the closing of the business combination. On January 22, 2026, Mr. Kennedy informed Pubco he can no longer accept the nomination. IWAC now nominates Isaac Freites instead, and the anticipated Pubco board is expected to include Douglas Benoit, Isaac Freites, and Donald Fell as Class I directors, Matthew Malriat and Qun Hua Wang as Class II directors, and Binson Lau as Class III director.
Integrated Wellness Acquisition Corp held an extraordinary general meeting on December 12, 2025, where shareholders approved several key proposals. They extended the deadline to complete an initial business combination from December 15, 2025 to March 16, 2026, while also allowing the board to choose to wind up the company earlier if it decides. Shareholders approved eliminating the prior limitation that prevented redemptions if net tangible assets would fall below $5,000,001 and ratified BDO USA, LLP as auditor for the year ending December 31, 2025.
In connection with the meeting, holders of 1,109,590 Class A ordinary shares chose to redeem their shares for a pro rata portion of the funds in the trust account. The company estimates the per share redemption amount at approximately $12.90 and expects to remove about $14.3 million from the trust account to pay these holders. The charter amendment implementing the extension and related changes was filed with the Cayman Islands Registrar of Companies on December 12, 2025.
Integrated Wellness Acquisition Corp reported that its shareholders have approved its previously announced business combination with Btab Ecommerce Group, Inc., a global e-commerce and technology company. This vote is a key step toward closing the transaction, but the deal is not yet complete. Closing remains subject to several conditions, including exchange listing approvals for the combined company and securing enough financing to meet applicable listing requirements.
The disclosure emphasizes that many risks could still affect whether and when the business combination is completed, such as potential redemptions of public shares, meeting Nasdaq initial listing standards, and satisfying minimum cash conditions. Investors are directed to previously filed proxy materials and risk factor sections for more detailed information about the transaction, its structure, and the uncertainties that could impact its completion and the future performance of Btab as a public company.